Hostname: page-component-7479d7b7d-t6hkb Total loading time: 0 Render date: 2024-07-08T22:54:54.981Z Has data issue: false hasContentIssue false

Drug eruption due to bupropion, a case report

Published online by Cambridge University Press:  23 March 2020

N. Salgado*
Affiliation:
Hospital Dr. Rodriguez Lafora, Psiquiatria, Madrid, Spain
S. Benavente
Affiliation:
Hospital Universitario 12 de Octubre, Psiquiatria, Madrid, Spain
J.M. Coll
Affiliation:
Hospital Universitario La Paz, Psiquiatria, Madrid, Spain
A. Vives
Affiliation:
Hospital Dr. Rodriguez Lafora, Psiquiatria, Madrid, Spain
*
* Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

We present a clinical case of eruption caused by the use of bupropion. Bupropion is known to cause hypersensitivity reactions.

Case report

We report the case of a 48-year-old female who was diagnosed of depressive disorder. She went to emergency because a few days after prescribing bupropion (150 mg/24 h) scaly skin eruptions were found distributed along the skin. In the present case, after its introduction, bupropion was found to be a probable etiological agent. The patient was successfully treated with corticosteroids. Because of that, bupropion dosage was stopped and replaced with fluoxetine. No remissions and exacerbations were noticed in a month's follow up.

Discussion

In this case report, we present a patient with an eruption related to bupropion. The aetiological spectrum of eruption include drugs, infectious agents and food additives. Drugs attributing eruption include nonsteroidal anti-inflammatory drugs, antibiotics, and anti-epileptic drugs, antidepressive medication amongst others.

Conclusions

No specific diagnostic criterion exists for eruption and the diagnosis is purely based on clinical presentation. Diagnostic features, which suggest eruption, are the acute onset (or recurrent nature) and skin lesions.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EV1332
Copyright
Copyright © European Psychiatric Association 2016
Submit a response

Comments

No Comments have been published for this article.